Spero Therapeutics to Present at Upcoming September Investor Conferences

Rhea-AI Summary

Spero Therapeutics (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focusing on rare diseases and multi-drug resistant bacterial infections, has announced its participation in two upcoming investor conferences in September 2024:

1. H.C. Wainwright 26th Annual Global Investment Conference in New York, NY (September 9-11, 2024)
- Presentation: September 10, 2024, 4:00 - 4:30 PM ET

2. Cantor's Global Healthcare Conference in New York, NY (September 17-19, 2024)
- Fireside Chat: September 17, 2024, 1:20 - 1:50 PM ET

Sath Shukla, President and CEO of Spero Therapeutics, will present at both events and be available for one-on-one meetings. Webcasts of both presentations will be accessible through Spero's website, with replays available after the events.

News Market Reaction – SPRO

+1.53%

+1.53% Session move

In the trading session that priced this news, SPRO gained 1.53%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CAMBRIDGE, Mass., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas involving rare diseases and multi-drug resistant (MDR) bacterial infections, today announced that Sath Shukla, President and Chief Executive Officer of Spero Therapeutics, will present and be available for one-on-one meetings at the H.C. Wainwright 26^th Annual Global Investment Conference to be held in New York, NY, September 9^th – 11^th, 2024. He will also participate in a fireside chat and be available for one-on-one meetings at Cantor’s Global Healthcare Conference in New York, NY, September 17^th – 19^th, 2024. Details are as follows:

H.C. Wainwright 26th Annual Global Investment Conference
Presentation Date:	September 10, 2024
Time:	4:00 - 4:30 PM ET
Webcast link:	Company Presentation
Cantor’s Global Healthcare Conference
Analyst Fireside Chat:	September 17, 2024
Time:	1:20 - 1:50 PM ET
Webcast link:	Fireside Chat

The webcasts may also be accessed through Spero’s website on the “Events and Presentations” page (https://www.sperotherapeutics.com/investor-relations). A replay will be available on the website following the conclusion of the event.

About Spero Therapeutics
Spero Therapeutics, headquartered in Cambridge, Massachusetts, is a multi-asset, clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and MDR bacterial infections.
For more information, visit https://sperotherapeutics.com.

Investor Relations Contact:
Shai Biran, PhD
Spero Therapeutics
IR@Sperotherapeutics.com

Media Inquiries:
media@sperotherapeutics.com

FAQ

When is Spero Therapeutics (SPRO) presenting at the H.C. Wainwright Global Investment Conference in September 2024?

Spero Therapeutics (SPRO) is presenting at the H.C. Wainwright 26th Annual Global Investment Conference on September 10, 2024, from 4:00 to 4:30 PM ET.

What is the date and time of Spero Therapeutics' (SPRO) fireside chat at Cantor's Global Healthcare Conference in 2024?

Spero Therapeutics (SPRO) will participate in a fireside chat at Cantor's Global Healthcare Conference on September 17, 2024, from 1:20 to 1:50 PM ET.

Who will represent Spero Therapeutics (SPRO) at the September 2024 investor conferences?

Sath Shukla, President and Chief Executive Officer of Spero Therapeutics, will represent the company at both the H.C. Wainwright and Cantor's Global Healthcare conferences in September 2024.

Where can investors access the webcasts of Spero Therapeutics' (SPRO) September 2024 conference presentations?

Investors can access the webcasts through Spero Therapeutics' website on the 'Events and Presentations' page (https://www.sperotherapeutics.com/investor-relations). Replays will be available on the website after the events.